What is it about?
Endometriosis recurrence post conservative surgery is a serious reproductive health challenge affecting women worldwide; therefore, cost-effective strategies are warranted in near future to significantly reduce the increasing incidence of such adverse events.
Featured Image
Why is it important?
My article has been meticulously drafted and aptly highlights the ever-increasing public health challenge associated with recurrent endometriosis after conservative surgery in a well-defined patient population subset of distinct ethnicity. Future public health strategies should be robustly designed and implemented for meningful women-centric research globally.
Perspectives
I, Dr. Saumya Pandey Ph.D., have been an active public health and biomedical research investigator in reproductive immunology including Toll-like receptor-mediated cervical cancer and infertility, and feel that gene-epidemiology research should be encouraged and funded in near future for design of predictive biomarkers in endometriosis management in women worldwide. DR. SAUMYA PANDEY PH.D. DRSAUMYAPANDEY11@GMAIL.COM Lucknow, India (December 28, 2018).
DR. SAUMYA PANDEY
Read the Original
This page is a summary of: Re: Medical therapy for preventing recurrent endometriosis after conservative surgery: a cost-effectiveness analysis, BJOG An International Journal of Obstetrics & Gynaecology, August 2017, Wiley,
DOI: 10.1111/1471-0528.14816.
You can read the full text:
Contributors
The following have contributed to this page
